Multidisciplinary Management in the Perioperative Era of MIBC

In this episode, “Multidisciplinary Management in the Perioperative Era of MIBC,” the panelists explore how perioperative treatment strategies are reshaping clinical workflows and multidisciplinary care for patients with muscle-invasive bladder cancer (MIBC). The expert urologic oncology faculty discuss how the introduction of newer systemic therapies has expanded treatment options for both cisplatin-eligible and cisplatin-ineligible patients, requiring increasingly close collaboration between urologists, medical oncologists, and radiation oncologists.

Throughout the discussion, the panel highlights how perioperative decision-making has become more nuanced in the modern era, particularly as patients who historically may have proceeded directly to surgery are now being considered for systemic therapy. The faculty emphasize the importance of timely referral patterns, ongoing communication between specialties, and individualized treatment planning based on patient characteristics, biomarker data, imaging findings, and surgical pathology.

The panelists also examine challenges associated with managing patients who have incomplete responses to systemic therapy, including those with persistent locally advanced disease or treatment-related tissue changes that may complicate surgery. In addition, the discussion explores the increasing complexity of monitoring patients in potential bladder-sparing paradigms and the need for specialized expertise in surveillance, cystoscopic evaluation, and transurethral resection techniques. The faculty emphasize that while perioperative therapies have created exciting opportunities to improve outcomes in MIBC, successful implementation requires thoughtful multidisciplinary coordination and careful patient selection. The panel concludes by underscoring the importance of maintaining patient safety while integrating evolving perioperative strategies into routine clinical practice.

The next episode in this series, “Practical Integration of Perioperative Therapy in MIBC,” features the panelists discussing practical strategies for incorporating newer perioperative therapies into multidisciplinary management of muscle-invasive bladder cancer. The panel also highlights evolving surgical considerations, collaboration with medical oncology, and future directions for clinical research in MIBC.